International Clinical Trial: Can the Werfen GEM Hemochron 100 activated clotting time be used to monitor anticoagulation in prolonged baseline activated partial thromboplastin time?

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN91025247) titled 'Can the Werfen GEM Hemochron 100 activated clotting time be used to monitor anticoagulation in prolonged baseline activated partial thromboplastin time?' on Sept. 4.

Study Type: Observational

Study Design: Observational case-control study (Treatment)

Primary Sponsor: Blackpool Teaching Hospitals NHS Foundation Trust

Condition: Patients undergoing cardiopulmonary bypass with a prolonged baseline activated partial thromboplastin time (aPTT) Surgery

Intervention: This is a case-control study, utilising and control group of participants and a study group formed from two subgroups, A and B. This methodology has...